Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Haura

Showing results (91-100 of 213) with videos related to

Pageof 22
Sort By:
Bioinformatics (Oxford, England)|June 15, 2019
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysisQian Li, Kate Fisher, Wenjun Meng, et al.
JTO Clinical and Research Reports|October 10, 2024
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression PanelHilal Ozakinci, Aileen Y Alontaga, Pedro Cano, et al.
ACS Chemical Biology|March 21, 2022
Deubiquitinase Vulnerabilities Identified through Activity-Based Protein Profiling in Non-Small Cell Lung CancerShikha Mahajan, Anurima Majumder, Paul A Stewart, et al.
International Journal of Oncology|July 7, 2009
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J McConnell, Bin Yu, et al.
Journal of Proteome Research|August 2, 2013
A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsiesIvo Chamrád, Uwe Rix, Alexey Stukalov, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
A Fast-Tracking Sample Preparation Protocol for Proteomics of Formalin-Fixed Paraffin-Embedded Tumor TissuesLancia N F Darville, John H Lockhart, Sudhir Putty Reddy, et al.
Proteomes|February 4, 2017
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung CancerJae-Young Kim, Paul A Stewart, Adam L Borne, et al.
Science Signaling|January 19, 2017
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancerRobert M Gemmill, Patrick Nasarre, Joyce Nair-Menon, et al.
International Journal of Oncology|December 5, 2025
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J Mcconnell, Bin Yu, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 2, 2016
Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer PatientsLauren R Meltzer, Cathy D Meade, Diana B Diaz, et al.
Pageof 22

Showing results (91-100 of 213) with videos related to

Sort By:
Pageof 22
Bioinformatics (Oxford, England)|June 15, 2019
GMSimpute: a generalized two-step Lasso approach to impute missing values in label-free mass spectrum analysisQian Li, Kate Fisher, Wenjun Meng, et al.
JTO Clinical and Research Reports|October 10, 2024
Unveiling the Molecular Features of SCLC With a Clinical RNA Expression PanelHilal Ozakinci, Aileen Y Alontaga, Pedro Cano, et al.
ACS Chemical Biology|March 21, 2022
Deubiquitinase Vulnerabilities Identified through Activity-Based Protein Profiling in Non-Small Cell Lung CancerShikha Mahajan, Anurima Majumder, Paul A Stewart, et al.
International Journal of Oncology|July 7, 2009
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J McConnell, Bin Yu, et al.
Journal of Proteome Research|August 2, 2013
A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsiesIvo Chamrád, Uwe Rix, Alexey Stukalov, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
A Fast-Tracking Sample Preparation Protocol for Proteomics of Formalin-Fixed Paraffin-Embedded Tumor TissuesLancia N F Darville, John H Lockhart, Sudhir Putty Reddy, et al.
Proteomes|February 4, 2017
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung CancerJae-Young Kim, Paul A Stewart, Adam L Borne, et al.
Science Signaling|January 19, 2017
The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancerRobert M Gemmill, Patrick Nasarre, Joyce Nair-Menon, et al.
International Journal of Oncology|December 5, 2025
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJingchun Gao, Matthew J Mcconnell, Bin Yu, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 2, 2016
Development of a Targeted Smoking Relapse-Prevention Intervention for Cancer PatientsLauren R Meltzer, Cathy D Meade, Diana B Diaz, et al.
Pageof 22